Mirae Asset Global ETFs Holdings’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Sell
140,055
-12,556
-8% -$83.6K ﹤0.01% 1552
2026
Q1
$832K Sell
152,611
-19,559
-11% -$110K ﹤0.01% 1607
2025
Q4
$1.21M Sell
172,170
-12,248
-7% -$95.9K ﹤0.01% 1414
2025
Q3
$1.43M Sell
184,418
-228
-0.1% -$1.78K ﹤0.01% 1299
2025
Q2
$1.61M Sell
184,646
-9,068
-5% -$65.7K ﹤0.01% 1205
2025
Q1
$1.54M Buy
193,714
+5,235
+3% +$53K ﹤0.01% 1270
2024
Q4
$1.71M Sell
188,479
-20,884
-10% -$202K ﹤0.01% 1226
2024
Q3
$1.92M Buy
209,363
+81,243
+63% +$672K ﹤0.01% 1147
2024
Q2
$1.25M Buy
+128,120
New +$1.56M ﹤0.01% 1339

Other funds holding TDOC

Mirae Asset Global ETFs Holdings's TDOC Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Teladoc Health (TDOC) stake by 8.2% in Q2 2026, selling an estimated $83.6K and leaving 140,055 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1552.

Mirae Asset Global ETFs Holdings first reported a position in TDOC in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.92M in Q3 2024. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 140,055 shares of Teladoc Health worth $1.19M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 12,556 Teladoc Health shares in Q2 2026, an estimated $83.6K.
  • Teladoc Health made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1552 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Teladoc Health in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Teladoc Health position peaked at $1.92M in Q3 2024.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.